Concentration and volume effects in thermochemical ablation in vivo: Results in a porcine model

International Journal of Hyperthermia

Volumn 28, Issue 2, 2012, Pages 113-121

  Cressman, Erik N K ^a,f   Geeslin, Matthew G ^a   Shenoi, Mithun M ^a,b   Hennings, Leah J ^c   Zhang, Yan ^d   Iaizzo, Paul A ^e,f   Bischof, John C ^b,f  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^b University of Minnesota   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Animal model; Coagulation necrosis; Hepatocellular carcinoma; Hyperthermia; Thermochemical ablation

Indexed keywords

ACETIC ACID; FORMALDEHYDE; SODIUM HYDROXIDE;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HEART RATE; IN VIVO STUDY; LIVER; LIVER SURGERY; NEEDLE; NONHUMAN; SWINE; TEMPERATURE MEASUREMENT; THERMOCHEMICAL ABLATION;

ABLATION TECHNIQUES; ACETIC ACID; ANIMALS; HOT TEMPERATURE; HYPERTHERMIA, INDUCED; LIVER; MODELS, ANIMAL; NECROSIS; SODIUM HYDROXIDE; SWINE;

EID: 84863133174     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2011.644621     Document Type: Article

References (41)

1. Kuo YH, Lu SN, Chen CL, Cheng YF, Lin CY, Hung CH, et al. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Eur J Cancer 2010;46:744-751.
2. Schumacher PA, Powell JJ, MacNeill AJ, Buczkowski AK, Erb SR, Ho SG, et al. Multimodal therapy for hepatocellular carcinoma: A complementary approach to liver transplantation. Ann Hepatol 2010;9:23-32.
3. Cabibbo G, Enea M, Attanasio M, Bruix J, Craxi A, Camma C. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 2010;51:1274-1283.
4. Rimassa L, Santoro A. Sorafenib therapy in advanced hepatocellular carcinoma: The SHARP trial. Expert Rev Anticancer Ther 2009;9:739-745.
5. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390.
6. Lee WJ, Lee JL, Chang SE, Lee MW, Kang YK, Choi JH, et al. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. Br J Dermatol 2009;161:1045-1051.
7. Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol 2010;101:476-480.
8. Raoul JL, Sangro B, Forner A, Mazzaferro V, Piscaglia F, Bolondi L, et al. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 2011;37(3):212-220.
9. Kooby DA, Egnatashvili V, Srinivasan S, Chamsuddin A, Delman KA, Kauh J, et al. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 2010;21:224-230.
10. Ibrahim SM, Lewandowski RJ, Sato KT, Gates VL, Kulik L, Mulcahy MF, et al. Radioembolization for the treatment of unresectable hepatocellular carcinoma: A clinical review. World J Gastroenterol 2008;14:1664-1669. (Pubitemid 351493372)
11. Clark TW. Chemical ablation of liver cancer. Tech Vasc Interv Radiol 2007;10:58-63. (Pubitemid 350008081)
12. Clark TW, Soulen MC. Chemical ablation of hepatocellular carcinoma. J Vasc Interv Radiol 2002;13:S245-252.
13. Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis. Surg Oncol 2010;19: E22-32.
14. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: Updated review in 2010. Oncology 2010;78:S113-124.
15. Cho YB, Lee KU, Suh KS, Kim YJ, Yoon JH, Lee HS, et al. Hepatic resection compared to percutaneous ethanol injection for small hepatocellular carcinoma using propensity score matching. J Gastroenterol Hepatol 2007;22:1643-1649. (Pubitemid 47383334)
16. Fartoux L, Arrive L, Andreani T, Serfaty L, Chazouilleres O, Tubiana JM, et al. Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. Gastroenterol Clin Biol 2005;29:1213-1219. (Pubitemid 43170250)
17. Tsai WL, Cheng JS, Lai KH, Lin CP, Lo GH, Hsu PI, et al. Clinical trial: Percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma - A long-term follow-up study. Aliment Pharmacol Ther 2008; 28:304-311.
18. Schoppmeyer K, Weis S, Mossner J, Fleig WE. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database Syst Rev 2009;3:CD006745.
19. Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgro G, Burroughs AK. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis. J Hepatol 2010;52:380-388.
20. Bouza C, Lopez-Cuadrado T, Alcazar R, Saz-Parkinson Z, Amate JM. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 2009;9:31.
21. Mahnken AH, Bruners P, Gunther RW. Local ablative therapies in HCC: Percutaneous ethanol injection and radiofrequency ablation. Dig Dis 2009;27:148-156.
22. Lencioni R, Crocetti L, Cioni D, Pina CD, Oliveri F, De Simone P, et al. Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multipronged injection needle: Results of a pilot clinical study. J Vasc Interv Radiol 2010;21:1533-1538.
23. Kuang M, Lu MD, Xie XY, Xu HX, Xu ZF, Liu GJ, et al. Ethanol ablation of hepatocellular carcinoma up to 5.0cm by using a multipronged injection needle with high-dose strategy. Radiology 2009.
24. Ho CS, Kachura JR, Gallinger S, Grant D, Greig P, McGilvray I, et al. Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: Efficacy and safety. Cardiovasc Intervent Radiol 2007;30:241-247. (Pubitemid 46147115)
25. Arnulf F, Monika S, Herwig S, Monika H, Johannes PD, Gregor U, et al. Atropine for prevention of cardiac dysrhythmias in patients with hepatocellular carcinoma undergoing percutaneous ethanol instillation: A randomized, placebocontrolled, double-blind trial. Liver Int 2009;29:715-720.
26. Burton KR, O'Dwyer H, Scudamore C. Percutaneous ethanol ablation of hepatocellular carcinoma: Periprocedural onset alcohol toxicity and pancreatitis following conventional percutaneous ethanol ablation treatment. Can J Gastroenterol 2009;23:554-556.
27. Sidi A, Naik B, Urdaneta F, Muehlschlegel JD, Kirby DS, Lobato EB. Treatment of ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs, by sildenafil analogue (UK343-664) or nitroglycerin. Ann Card Anaesth 2008;11:97-104.
28. Sidi A, Naik B, Muehlschlegel JD, Kirby DS, Lobato EB. Ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs. Br J Anaesth 2008;100: 568-569. (Pubitemid 351773634)
29. Farnam JL, Smith BC, Johnson BR, Estrada R, Edelman TL, Farah R, et al. Thermochemical ablation in an ex-vivo porcine liver model using acetic acid and sodium hydroxide: Proof of concept. J Vasc Interv Radiol 2010;21:1573-1578.
30. Cressman ENK, Shenoi MM, Edelman TL, Geeslin MG, Hennings LJ, Zhang Y, et al. In vivo comparison of simultaneous v sequential injection technique for thermochemical ablation in a porcine model. Int J Hyperthermia 2011:in press.
31. Geeslin MG, Cressman ENK. Thermochemical ablation: A device for a novel interventional concept. J Med Devices 2011:in press.
32. National Research Council, National Academy of Sciences. Guide for the Care and Use of Laboratory Animals, 8th edition. Bethesda, MD: National Institutes of Health, 2011. Available at: http://grants.nih.gov/grants/olaw/ Guide-forthe- care-and-use-of-Laboratory-animals.pdf (accessed 25 October 2011).
33. Okuda S, Kuroda K, Oshio K, Mulkern RV, Colucci V, Morrison PR, et al. MR-based temperature monitoring for hot saline injection therapy. J Magn Reson Imaging 2000;12: 330-338. (Pubitemid 30612878)
34. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd III GD, Dupuy DE, et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009;20:S377-390.
35. Mulier S, Ni Y, Frich L, Burdio F, Denys AL, De Wispelaere JF, et al. Experimental and clinical radiofrequency ablation: Proposal for standardized description of coagulation size and geometry. Ann Surg Oncol 2007;14: 1381-1396. (Pubitemid 46536796)
36. Tsai IC, Huang JW, Chu TS, Wu KD, Tsai TJ. Factors associated with metabolic acidosis in patients receiving parenteral nutrition. Nephrology 2007;12:3-7.
37. Freeman LA, Anwer B, Brady RP, Smith BC, Edelman TL, Misselt AJ, et al. In vitro thermal profile suitability assessment of acids and bases for thermochemical ablation: Underlying principles. J Vasc Interv Radiol 2010;21:381-385.
38. Yarmolenko PS, Moon EJ, Landon C, Manzoor A, Hochman DW, Viglianti BL, et al. Thresholds for thermal damage to normal tissues: An update. Int J Hyperthermia 2011;27:320-343.
39. Tapani E, Vehmas T, Voutilainen P. Effect of injection speed on the spread of ethanol during experimental liver ethanol injections. Acad Radiol 1996;3:1025-1029.
40. Shimizu S, McLaren WM, Matubayasi N. The Hofmeister series and protein-salt interactions. J Chem Phys 2006;124: 234905.
41. Zhang Y, Cremer PS. Interactions between macromolecules and ions: The Hofmeister series. Curr Opin Chem Biol 2006;10:658-663. (Pubitemid 44821892)